Fees in Respect of Dealer’s Licences Regulations
Marginal note:Activity
28 (1) If an application to amend an establishment licence seeks to add an activity at a building, the fee for the examination of the application for each building at which the activity is to be added is,
(a) if the amendment seeks to authorize the holder to fabricate drugs, the basic fee set out in item 1, column 2, of Schedule 2;
(b) if the amendment seeks to authorize the holder to package/label drugs but not to fabricate drugs, the basic fee set out in item 1, column 2, of Schedule 3;
(c) if the amendment seeks to authorize the holder to import drugs but not to fabricate or package/label drugs, the basic fee set out in item 1, column 2, of Schedule 4;
(d) if the amendment seeks to authorize the holder to distribute drugs (other than drugs that are listed in Schedule C to the Food and Drugs Act and that are in dosage form) as a distributor referred to in paragraph C.01A.003(b) of the Food and Drug Regulations but not to fabricate, package/label or import drugs, the basic fee set out in item 1, column 2, of Schedule 4; and
(e) if the amendment seeks to authorize the holder to distribute drugs as a distributor referred to in paragraph C.01A.003(a) of the Food and Drug Regulations, to distribute drugs that are listed in Schedule C to the Food and Drugs Act and that are in dosage form as a distributor referred to in paragraph C.01A.003(b) of those Regulations, to wholesale drugs or to conduct more than one of those activities, but not to fabricate, package/label or import drugs or to distribute drugs (other than drugs that are listed in Schedule C to that Act and that are in dosage form) as a distributor referred to in paragraph C.01A.003(b) of those Regulations, the basic fee set out in section 23.
Marginal note:Category
(2) Subject to subsection (3), if an application to amend an establishment licence seeks to add a category in respect of an activity that is authorized by the licence at a building, the fee for the examination of the application for each building at which the category is to be added is,
(a) if the amendment seeks to authorize the holder to fabricate a drug of an additional category, the basic fee set out in item 1, column 2, of Schedule 2;
(b) if the amendment seeks to authorize the holder to package/label a drug of an additional category, the basic fee set out in item 1, column 2, of Schedule 3;
(c) if the amendment seeks to authorize the holder to import a drug of an additional category, the basic fee set out in item 1, column 2, of Schedule 4;
(d) if the amendment seeks to authorize the holder to distribute a drug (other than a drug that is listed in Schedule C to the Food and Drugs Act and that is in dosage form) of an additional category as a distributor referred to in paragraph C.01A.003(b) of the Food and Drug Regulations, the basic fee set out in item 1, column 2, of Schedule 4;
(e) if the amendment seeks to authorize the holder to distribute a drug of an additional category as a distributor referred to in paragraph C.01A.003(a) of the Food and Drug Regulations, to distribute a drug that is listed in Schedule C to the Food and Drugs Act and that is in dosage form as a distributor referred to in paragraph C.01A.003(b) of those Regulations or to wholesale a drug of an additional category, the basic fee set out in section 23; and
(f) if the amendment seeks to authorize the holder to test a drug of an additional category, the basic fee set out in section 24.
Marginal note:Included categories
(3) If an application to amend an establishment licence seeks to add a category in respect of more than one activity referred to in paragraphs (2)(a) to (f), the fee payable under subsection (2) for the examination of the application is the highest applicable fee for those activities.
- SOR/2017-260, s. 6
- Date modified: